Nicholas R Rydzewski1, Kyle T Helzer2, Matthew Bootsma2

  • 1Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Human Oncology, University of Wisconsin, Madison, WI.

PubMed
概括

开发辐射瘤生物标志物是个性化癌症医学的关键. 机器学习和"omics"数据分析有助于预测患者对放射治疗的反应,改善治疗决策.

相关概念视频